1728-24-1

Basic information

• Product Name: 1,4-Dioxaspiro[4.6]undec-6-ene
• Synonyms: 1,4-Dioxaspiro[4.6]undec-6-ene
• CAS NO: 1728-24-1
• Molecular Formula: C₉H₁₄O₂
• Molecular Weight: 154.2063
• Mol File: 1728-24-1.mol

Chemical Properties

• Boiling Point: 227.3°Cat760mmHg
• Flash Point: 90.7°C
• Appearance: /
• Density: 1.05g/cm³
• Vapor Pressure: 0.117mmHg at 25°C
• Refractive Index: 1.5
• CAS DataBase Reference: 1,4-Dioxaspiro[4.6]undec-6-ene(CAS DataBase Reference)
• NIST Chemistry Reference: 1,4-Dioxaspiro[4.6]undec-6-ene(1728-24-1)
• EPA Substance Registry System: 1,4-Dioxaspiro[4.6]undec-6-ene(1728-24-1)

Safety Data

• Hazardous Substances Data: 1728-24-1(Hazardous Substances Data)

Usage

Uses

Used in Fragrance Industry:
1,4-Dioxaspiro[4.6]undec-6-ene is used as a fragrance ingredient for its pleasant odor, contributing to the creation of various scent profiles in perfumes, cosmetics, and other fragranced products.
Used in Chemical Industry:
1,4-Dioxaspiro[4.6]undec-6-ene serves as a chemical intermediate, playing a crucial role in the synthesis of other compounds for various applications across different industries.
It is important to handle 1,4-Dioxaspiro[4.6]undec-6-ene with care, as it may pose potential health hazards if not used and stored properly.

InChI:InChI=1/C9H14O2/c1-2-4-6-9(5-3-1)10-7-8-11-9/h3,5H,1-2,4,6-8H2

Upstream product

• 502-42-1 cycloheptanone 
• 70562-63-9 2-Brom-cycloheptanon-ethylenketal 
• 99061-99-1 6-chloro-1,4-dioxaspiro[4.6]undecane 

Downstream Products

• 132113-70-3 Toluene-4-sulfonic acid 1,4-dioxa-spiro[4.6]undec-6-en-8-yl ester 
• 42812-43-1 3-phenyl-(3ar,8ac)-3a,4,5,6,7,8a-hexahydro-cyclohepta[d]isoxazol-8-one 
• 102560-03-2 2,7-bis-(4-methyl-benzyl)-cycloheptatrienone 
• 3008-39-7 cycloheptane-1,2-dione 
• 73745-00-3 (+/-)-N-benzoyl-3-methylaminocycloheptanone 
• 685109-62-0 3-(2-cyclohexenylmethyl)bicyclo[5.1.0]oct-2-en-1-yl trimethylsilyl ether 
• 1194-18-9 cycloheptane-1,3-dione 
• 42812-86-2 3-phenyl-(3ar,8ac)-3a,4,5,6,7,8a-hexahydro-spiro[cyclohepta[d]isoxazole-8,2'-[1,3]dioxolane] 
• 42812-39-5 3-phenyl-(3ar,8ac)-3a,5,6,7,8,8a-hexahydro-spiro[cyclohepta[d]isoxazole-4,2'-[1,3]dioxolane] 
• 1121-66-0 2-Cyclohepten-1-one 
• 102560-26-9 2,7-bis-(2-methoxy-benzylidene)-cyclohept-3-enone 
• 102477-79-2 2,7-dibenzylidene-cyclohept-3-enone 
• 102560-04-3 2,7-bis-(4-methyl-benzylidene)-cyclohept-3-enone 

Relevant articles and documents

CERTAIN FUSED PYRROLECARBOXAMIDES A NEW CLASS OF GABA BRAIN RECEPTOR LIGANDS

Disclosed are compounds of formula I: STR1 wherein R 8 and R. sub.9 independently represent hydrogen or organic substituents; W represents optionally substituted thiazolyl or quinoxalinyl; X is hydrogen, hydroxy or lower alkyl; andT is hydrogen, halogen, hydroxy, nitro, amino or alkyl,which compounds are highly selective agonists, antagonists or inverse agonists for GABAa brain receptors or prodrugs of agonists, antagonists or inverse agonists for GABAa brain receptor. These compounds are useful in the diagnosis and treatment of anxiety, sleep and seizure disorders, overdose with benzodiazepine drugs and for enhancement of memory.

CERTAIN PYRROLO PYRIDINE-3-CARBOXAMIDES; A NEW CLASS OF GABA BRAIN RECEPTOR LIGANDS

The present invention encompasses structures of the formula: STR1 or the pharmaceutically acceptable non-toxic salts thereof wherein: STR2 wherein: W represents substituted or unsubstituted phenyl;X is hydrogen, hydroxy or lower alkyl; T is hydrogen, halogen, hydroxy, nitro, amino or alkyl; R. sub.3 is hydrogen or an organic group;R 4 is hydrogen or substituted or unsubstituted organic substituent;R 5 and R 6 represent organic, and inorganic substituents; andn is 1, 2, 3, or 4, which compounds are highly selective agonists, antagonists or inverse agonists for GABAa brain receptors or prodrugs of agonists, antagonists or inverse agonists for GABAa brain receptors. These compounds are useful in the diagnosis and treatment of anxiety, sleep and seizure disorders, overdose with benzodiazepine drugs and for enhancement of memory.

Synthetic studies on the 1-hydroxy nortropane system: An approach to Calystegines.

A general synthetic strategy for 1-hydroxy nortropane skeleton, the common feature of calystegines is described.